BRKRMID

Bruker Corporation

HealthcareMedical - Devices
$57.23
$0.03(+4.57%)
52W$28.53
$64.54
Updated Jun 22, 02:00 AM
RSI57
RS Rating90/99
Beta1.57
Volatility55%
F-Score4/9
Mkt Cap$8.7B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Bruker Corporation is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 90), indicating clear outperformance against the broad market. Earnings contraction of 79% provides fundamental context to the price action. However, price is extended 24% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
90
out of 99
Market Leader
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
1.57
vs S&P 500
HIGH BETA
52W Position
80%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$46.32
50 SMA > 100 SMA$42.27
100 SMA > 150 SMA$44.12
150 SMA > 200 SMA$41.99

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$55.40+3.30%ABOVE
50 SMA$46.32+23.55%ABOVE
100 SMA$42.27+35.41%ABOVE
150 SMA$44.12+29.70%ABOVE
200 SMA$41.99+36.30%ABOVE

Price Performance

1D+4.6%
1W+3.7%
1M+33.9%
3M+68.2%
6M+28.1%
YTD+19.0%
1Y+48.9%
3Y-8.8%
52-Week Trading Range80% from low
$57.23
52W Low$28.53
52W High$64.54

Technical Indicators

RSI (14)NEUTRAL
57.0
305070
Setup ScoreCOOL
3/10
Base depth: 54.9%

Risk Profile

Beta
1.57
52W Vol
55%
ATR
$3.08
Max DD (1Y)
-40%

Volume Analysis

Today
1.74M
50D Avg
2.36M
Vol Ratio
0.74x
Liquidity
LIQUID

Earnings Momentum

Q2'25
$0.05
Q3'25-252%
$-0.41
Q4'25+9%
$0.10
Q1'26-79%
$0.02
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+7.79%
5 Years:+11.57%
3 Years:+10.74%
TTM:+0.36%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-145.98%

Stock Price CAGR

10 Years:+8.91%
5 Years:-4.56%
3 Years:-8.78%
1 Year:+48.92%

Return on Equity

10Y Avg:18.6%
5Y Avg:18.8%
3Y Avg:13.4%
Last Year:-0.5%

Key Metrics

Market Cap$8.7B
Gross Margin45.9%
Net Margin-0.3%
Piotroski F-Score4/9

Frequently Asked Questions

Is BRKR in an uptrend right now?

BRKR has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is BRKR overbought or oversold?

BRKR's RSI (14) is 57. The stock is in neutral territory, neither overbought nor oversold.

Is BRKR outperforming the market?

BRKR has a Relative Strength (RS) Rating of 90 out of 99. Yes, BRKR is a market leader, outperforming 90% of all stocks over the past 12 months.

Where is BRKR in its 52-week range?

BRKR is trading at $57.23, which is 89% of its 52-week high ($64.54) and 80% above its 52-week low ($28.53).

How volatile is BRKR?

BRKR has a Beta of 1.57 and 52-week volatility of 55%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.